The overall goal of this research is the design, development and in vivo testing of a biologically active, collagen-based coil for the embolization of cerebral aneurysms. Our research hypothesis for this investigation is that type I collagen-based material will promote and facilitate fibrous tissue formation within the aneurysm cavity and therefore, will stabilize the aneurysm for effective aneurysm occlusion. The hypothesis is based on numerous previous studies that collagen surface enhances cell adhesion, proliferation and extracellular cellular matrix synthesis, all of which contribute to fibrogenesis and fibrous tissue deposition, resulting in stable aneurysm occlusion. In phase I, we have developed a collagen-based coil prototype and tested the prototypes in vitro and in vivo in a rabbit saccular aneurysm model. Results of the in vivo studies demonstrated the feasibility of embolizing saccular aneurysms using coils constructed from purified type I collagen. However, several areas require improvement before the collagen-based coil can be used clinically. The coil must be deliverable, detachable, visible in vivo and retrievable. These improvements will be the subject of this phase II proposal.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44NS040630-03
Application #
6802434
Study Section
Special Emphasis Panel (ZRG1-SSS-W (10))
Program Officer
Jacobs, Tom P
Project Start
2000-09-01
Project End
2007-06-30
Budget Start
2004-07-01
Budget End
2007-06-30
Support Year
3
Fiscal Year
2004
Total Cost
$529,274
Indirect Cost
Name
Collagen Matrix, Inc.
Department
Type
DUNS #
176262442
City
Franklin Lakes
State
NJ
Country
United States
Zip Code
07417